Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Variable Rate Preferred Portfolio PS (VRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family Invesco PowerShares
  • Assets Under Management 1,960,560,200
  • Shares Outstanding, K 77,800

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.10 +0.28%
on 02/06/18
25.59 -1.64%
on 01/26/18
-0.33 (-1.29%)
since 01/22/18
3-Month
25.10 +0.28%
on 02/06/18
25.96 -3.04%
on 11/28/17
-0.73 (-2.82%)
since 11/22/17
52-Week
24.94 +0.92%
on 03/15/17
26.49 -4.97%
on 07/11/17
-0.21 (-0.83%)
since 02/22/17

Most Recent Stories

More News
Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma Provides Clinical Development Update

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Must-Follow ETF Moves as Finally Selloffs Set In

The broader market fell flat at the onset of February. So, follow these ETF strategies if you think the market would stay subdued ahead.

BTAL : 18.65 (+0.27%)
LVHE : 28.55 (unch)
PREF : 98.88 (+0.13%)
IDLV : 33.35 (+0.30%)
KBWD : 22.28 (-0.76%)
QQQ : 164.80 (-0.01%)
VRP : 25.17 (unch)
VXX : 43.82 (-1.22%)
YYY : 18.84 (+0.16%)
SLV : 15.66 (+0.77%)
DIA : 249.49 (+0.71%)
SPY : 270.40 (+0.13%)
GLD : 126.30 (+0.51%)
EPRF : 23.14 (+0.04%)
Must-Follow ETF Moves as Finally Selloffs Set In

The broader market fell flat at the onset of February. So, follow these ETF strategies if you think the market would stay subdued ahead.

BTAL : 18.65 (+0.27%)
LVHE : 28.55 (unch)
PREF : 98.88 (+0.13%)
IDLV : 33.35 (+0.30%)
KBWD : 22.28 (-0.76%)
QQQ : 164.80 (-0.01%)
VRP : 25.17 (unch)
VXX : 43.82 (-1.22%)
YYY : 18.84 (+0.16%)
SLV : 15.66 (+0.77%)
DIA : 249.49 (+0.71%)
SPY : 270.40 (+0.13%)
GLD : 126.30 (+0.51%)
EPRF : 23.14 (+0.04%)
PDMR Dealing

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma plc Operational Update and Financial Results for the Third Quarter Ended September 30, 2017

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases,...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma Reports Patient Enrollment Progressing Ahead of Schedule in Ongoing Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma to Announce Operational Update and Financial Results for the Third Quarter Ended September 30, 2017

Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients

Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces...

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)
Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva(R))

Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium

VRP : 25.17 (unch)
VRNA : 13.86 (+10.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Fund Summary

The PowerShares Variable Rate Preferred Portfolio is based on the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The Fund will generally invest at least 90% of its total assets in preferred securities that comprise the Index. The Index is a market capitalization-weighted...

See More

Key Turning Points

2nd Resistance Point 25.26
1st Resistance Point 25.21
Last Price 25.17
1st Support Level 25.13
2nd Support Level 25.10

See More

52-Week High 26.49
Fibonacci 61.8% 25.89
Fibonacci 50% 25.71
Fibonacci 38.2% 25.53
Last Price 25.17
52-Week Low 24.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.